| 产品详情 |
| Edit |   |
|---|
| Product Name | SUMO2, Recombinant, Human (Small Ubiquitin-Related Modifier 2, Sentrin2, SMT3B) |
|---|
| Description | Purity ~95% (RP-HPLC, SDS-PAGE). Small Ubiquitin-like Modifiers (SUMOs) are a family of small, related proteins that can be enzymatically attached to a target protein by a post-translational modification process termed sumoylation. Unlike ubiquitination, which targets proteins for degradation, sumoylation participates in a number of cellular processes, such as nuclear transport, transcriptional regulation, apoptosis, and protein stability. All SUMO proteins share the conserved ubiquitin domain and the C-terminal diglycine cleavage/attachment site. Human SUMO2, also known as Sentrin2 and SMT3B is synthesized as a 95aa, 11kD propeptide that contains a two aa C-terminal prosegment, and an 18aa N-terminal protein interacting region (aa33-50). Source: Recombinant protein corresponding to human SUMO2, a single, non-glycosylated polypeptide chain containing 95aa, expressed in E. coli. Molecular Weight: ~11kD |
|---|
| Size | 10ug |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 209217 |
|---|
| Price | |
|---|
| Order / More Info | SUMO2, Recombinant, Human (Small Ubiquitin-Related Modifier 2, Sentrin2, SMT3B) from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|